Evidence map›Paper›PMID 37548169›Full record

ArticleJournal of the American Heart Association2023

Protein Biomarkers of Early Menopause and Incident Cardiovascular Disease.

Mariana F Ramirez, Michael Honigberg, Dongyu Wang, Juhi K Parekh, Kamila Bielawski, Paul Courchesne, Martin D Larson, Daniel Levy, Joanne M Murabito, Jennifer E Ho and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Mariana F RamirezCardioVascular Institute and Division of Cardiology, Department of Medicine Beth Israel Deaconess Medical Center Boston MA USA.ORCID 0000-0002-1643-7894
Michael HonigbergCardiovascular Research Center and Division of Cardiology, Department of Medicine Massachusetts General Hospital Boston MA USA.ORCID 0000-0001-8630-5021
Dongyu WangCardioVascular Institute and Division of Cardiology, Department of Medicine Beth Israel Deaconess Medical Center Boston MA USA.ORCID 0000-0002-1317-2739
Juhi K ParekhCardioVascular Institute and Division of Cardiology, Department of Medicine Beth Israel Deaconess Medical Center Boston MA USA.ORCID 0009-0009-6510-0073
Kamila BielawskiCardiovascular Research Center and Division of Cardiology, Department of Medicine Massachusetts General Hospital Boston MA USA.ORCID 0009-0000-6523-106X
Paul CourchesneFramingham Heart Study Framingham MA USA.ORCID 0000-0001-5691-6913
Martin D LarsonFramingham Heart Study Framingham MA USA.ORCID 0000-0002-9631-1254
Daniel LevyFramingham Heart Study Framingham MA USA.ORCID 0000-0003-1843-8724
Joanne M MurabitoFramingham Heart Study Framingham MA USA.ORCID 0000-0002-0192-7516
Jennifer E HoCardioVascular Institute and Division of Cardiology, Department of Medicine Beth Israel Deaconess Medical Center Boston MA USA.ORCID 0000-0002-7987-4768
Emily S LauCardiovascular Research Center and Division of Cardiology, Department of Medicine Massachusetts General Hospital Boston MA USA.ORCID 0000-0001-9361-6397
Beth Israel Deaconess Medical Center · USMassachusetts General Hospital · USBoston University · USNational Heart Lung and Blood Institute · USFramingham Heart Study · US

Funding

Framingham Project/LevyZIAHL006001 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI LEVY, DANIEL · 2009 to 2025
$51.1M
Eicosanoid Profiles as Determinants of HFpEFR01HL140224 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HO, JENNIFER E · 2018 to 2021
$3.1M
The Association of Metabolic Disease and Pulmonary HypertensionR01HL134893 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HO, JENNIFER E · 2017 to 2021
$2.9M
Long-Term Endothelial Effects of COVID-19 in ObesityR01HL160003 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI HAMBURG, NAOMI MIRIAM, HO, JENNIFER E · 2022 to 2025
$2.8M
HFpEF Susceptibility in Women: The Role of InflammationK23HL159243 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Emily Lau · 2022 to 2026
$1.1M
Mentoring in Patient-Oriented and Translational HFpEF ResearchK24HL153669 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Jennifer E Ho · 2020 to 2026
$744k
Clonal hematopoiesis as a mediator of cardiovascular disease in women with premature menopauseK08HL166687 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HONIGBERG, MICHAEL · 2023 to 2025
$507k
THE FRAMINGHAM HEART STUDY-N01HC25195-268025195-268025195N01HC025195 · HC · TRUSTEES OF BOSTON UNIVERSITY · PI WOLF, PHILIP A · 2002 to 2006
–
NHLBI NIH HHS HHSN268201500001CNHLBI NIH HHS HHSN268201500001INHLBI NIH HHS K08 HL166687NHLBI NIH HHS K23 HL159243NHLBI NIH HHS K24 HL153669NHLBI NIH HHS N01 HC025195NHLBI NIH HHS R01 HL134893NHLBI NIH HHS R01 HL140224NHLBI NIH HHS R01 HL160003
6 · The paper itself

Abstract

Background Premature and early menopause are independently associated with greater risk of cardiovascular disease (CVD). However, mechanisms linking age of menopause with CVD remain poorly characterized. Methods and Results We measured 71 circulating CVD protein biomarkers in 1565 postmenopausal women enrolled in the FHS (Framingham Heart Study). We examined the association of early menopause with biomarkers and tested whether early menopause modified the association of biomarkers with incident cardiovascular outcomes (heart failure, major CVD, and all-cause death) using multivariable-adjusted linear regression and Cox models, respectively. Among 1565 postmenopausal women included (mean age 62 years), 395 (25%) had a history of early menopause. Of 71 biomarkers examined, we identified 7 biomarkers that were significantly associated with early menopause, of which 5 were higher in women with early menopause including adrenomedullin and resistin, and 2 were higher in women without early menopause including insulin growth factor-1 and CNTN1 (contactin-1) (Benjamini-Hochberg adjusted

Indexed as

Cardiovascular DiseasesMenopause, PrematureAdrenomedullinBiomarkersFemaleHumansMenopauseMiddle AgedRisk FactorsAdrenomedullinBiomarkersbiomarkersearly menopausewomen's health

Identifiers

PMID37548169
PMCPMC10492938
OpenAlexW4385620646

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.